Sanofi-Aventis is trying out its weight loss drug, Acomplia, as a treatment for type 2 diabetes. The French company presented a study at the American Diabetes Association meeting on Tuesday that ...

LONDON (Reuters) - European authorities said on Thursday Sanofi-Aventis's anti-obesity drug Acomplia should be withdrawn from sale over links to mental disorders, dealing a blow to the French ...

WASHINGTON, Feb. 14 (UPI) -- A major study released Tuesday indicates Sanofi-Aventis' weight-loss drug candidate Acomplia can help obese adults lose weight and keep it off for at least two years. The ...

The experimental diet drug Acomplia (search) not only takes off weight and reduces waist size, it also has staying power. Unlike many other diet medications that lose their effectiveness after a few ...

The FDA declined approving Sanofi-Aventis’ highly anticipated Acomplia (rimonabant) for smoking cessation but may give a green light to the drug for weight loss, the French drugmaker said in a ...

It looks like the end of the road for Sanofi-Aventis’ Acomplia after European regulators recommended the suspension of the controversial anti-obesity drug. It looks like the end of the road for Sanofi ...

PARIS (Reuters) - Sanofi-Aventis's Acomplia pill can significantly improve blood sugar levels in patients with type 2 diabetes while also reducing their weight, clinical trial data sponsored by the ...

Sanofi-Aventis has received some more bad news concerning Acomplia after researchers claimed that patients taking the obesity drug were at risk of suffering severe psychiatric side effects.

Sanofi-Aventis’ new obesity drug Acomplia could eventually generate sales of over $3 billion a year, its chairman told Reuters news service yesterday. “I can tell you that for such a product, in my ...

Mar. 24 -- WEDNESDAY, March 12 (HealthDay News) -- The weight-loss drug rimonabant has been associated with troubling psychiatric side effects, and now researchers think they have discovered why. A ...

A weight-loss drug used by thousands of UK patients should not be taken by people on anti-depressants, a European health watchdog warned yesterday. The European Medicines Agency (EMEA) said it was ...